Results 41 to 50 of about 41,522 (262)

The impact of asthma and its treatment on growth: an evidence‐based review

Jornal de Pediatria (Versão em Português), 2019
Objectives: To assess the impact of asthma and its treatment (inhaled corticosteroids and other control medications) on growth. Data sources: The authors searched PubMed (up to August 24, 2018) and screened the reference lists of retrieved articles ...
Linjie Zhang, Laura Belizario Lasmar, Jose A. Castro‐Rodriguez   +2 more
doaj   +3 more sources

EFFECT OF MODERATE DOSE OF INHALED BUDESONIDE ON HBA1C IN ASTHMATIC CHILDREN

National Journal of Medical Research, 2019
Objective: The objective of the study was to find out effect of inhaled corticosteroids on HbA1c. Methods: Asthma patients in the age group 5-15 years who were started on moderate doses of inhaled budesonide (400-800 microgram/day) for the first time
Wasim A Wani, Sheeraz A Dar, Mudasir N. Mir, Javeed I. Bhat, Bashir A Charoo   +4 more
doaj  

Associated Factors of Pneumonia in Individuals with Chronic Obstructive Pulmonary Disease (COPD) Apart from the Use of Inhaled Corticosteroids

Biomedicines, 2023
Inhaled corticosteroids (ICSs) are widely used in chronic obstructive pulmonary disease (COPD) and in combination with long-acting β2 agonists (LABAs) to reduce exacerbations and improve patient lung function and quality of life.
Rosario Lineros, Lourdes Fernández-Delgado, Antonio Vega-Rioja, Pedro Chacón, Bouchra Doukkali, Javier Monteseirin, David Ribas-Pérez   +6 more
doaj   +1 more source

Case‐malformed signal detection and prioritisation using EUROmediCAT data for pharmacovigilance in pregnancy

British Journal of Clinical Pharmacology, EarlyView.
Aim Many women take medications during pregnancy. However, the risk to the fetus from most medications is uncertain. Congenital anomalies are one of the leading causes of infant death and contribute to long‐term disability. Signal detection methods can be used to systematically identify possible medication–anomaly associations that require further ...
Hannah Johnson, Helen Dolk, Maria Loane, Christine Damase‐Michel, Joanne Given, Hedvig Nordeng, Jorieke E. H. Bergman, Iain Carey, Elly Den Hond, Ester Garne, Florence Rouget, Lea Bruneau, Isabelle Monier, Anke Rissmann, Mary O'Mahony, Miriam Gatt, Renée Lutke, Joanna Sichitiu, Elisa Ballardini, Alessio Coi, Clara Cavero Carbonell, David Tucker, Joan Morris   +22 more
wiley   +1 more source

Exploring the Relationship between Inhaled Corticosteroid Usage, Asthma Severity, and Sleep-Disordered Breathing: A Systematic Literature Review

Advances in Respiratory Medicine
(1) Background: Sleep-disordered breathing and asthma are often interrelated. Children and adults with asthma are more susceptible to sleep apnea. Inhaled corticosteroids effectively reduce inflammation and prevent structural changes in the airways ...
Marco Zaffanello, Giuliana Ferrante, Michele Piazza, Luana Nosetti, Laura Tenero, Giorgio Piacentini   +5 more
doaj   +1 more source

Effects of inhaled corticosteroids on bone [PDF]

The Netherlands Journal of Medicine, 1997
Inhaled corticosteroids (ICS) are the most effective therapy for asthma currently available. The increasing use of ICS raises the issue of possible adverse systemic effects. Since one of the most important side-effects of oral corticosteroids (OCS) is osteoporosis, this article focuses on current knowledge of the effects of ICS on bone.
Bootsma, G.P., Dekhuijzen, P.N.R., Festen, J., Herwaarden, C.L.A. van   +3 more
openaire   +4 more sources

Pharmacokinetics and safety of tezepelumab in children with mild, moderate or severe asthma and adolescents with mild‐to‐moderate asthma

British Journal of Clinical Pharmacology, EarlyView.
Abstract Aim Tezepelumab is a human monoclonal antibody that blocks the activity of thymic stromal lymphopoietin and is approved for adolescents and adults with severe asthma. This analysis assessed pharmacokinetics (PK), pharmacodynamics and safety of tezepelumab up to 85 days postdose in adolescents and children.
Anna Lundahl, Jonathan Grigg, Lubna Abuqayyas, Piotr Kuna, Gillian Hunter, Beata Pawlikowska, Jacob Leander, Michael Levin, Atul Gupta, James Paton, Katharine C. Pike, Jane R. Parnes, Gun Almqvist, Stephanie L. Roseti, on behalf of the study investigators   +14 more
wiley   +1 more source

Inhaled Corticosteroids in COPD: Determinants of Use and Trends in Patient Persistance with Treatment

Canadian Respiratory Journal, 2004
METHODS: The determinants of a new treatment with inhaled corticosteroids and secular trends in patient persistence with treatment among chronic obstructive pulmonary disease (COPD) patients were investigated.
Lucie Blais, Jean Bourbeau, Odile Dheehy, Jacques LeLorier   +3 more
doaj   +1 more source

Improvement of Reduced Bone Mineral Density by Intermittent Cyclical Etidronate in Postmenopausal Asthmatic Patients Receiving Inhaled Corticosteroids

Allergology International, 2005
Background: We have recently shown that early postmenopausal but not premenopausal asthmatic women treated with inhaled corticosteroids demonstrate reduced bone mineral density(BMD)and decreased serum intact osteocalcin levels.
Hiroyasu Yamamoto, Soji Kasayama, Mari Fujita, Kimie Fujita, Yasuhiko Morimoto, Ichiro Kawase, Akihiko Miyatake   +6 more
doaj   +1 more source

Impact of cumulative glucocorticoid exposure on vancomycin clearance in hospitalized children: A retrospective cohort study

British Journal of Clinical Pharmacology, EarlyView.
Prior glucocorticoid exposure is associated with modestly increased vancomycin clearance in hospitalized children, partly mediated by renal function and inflammation and may contribute to subtherapeutic early drug exposure. Abstract Introduction Augmented renal clearance (ARC) can lead to subtherapeutic vancomycin exposure in children.
Kouki Tomari, Ruud H. J. Verstegen, Cintia Cruz, Erin Chung, Aleena Azim, Shinya Ito, Tamorah R. Lewis   +6 more
wiley   +1 more source